Jazz Pharmaceuticals plcJAZZNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average, structural decline.
Left:
||||
Year-over-year research & development expense growth
Latest
4.04%
↓ 85% below average
Average (9y)
27.49%
Historical baseline
Range
High:58.78%
Low:4.04%
CAGR
-25.7%
Structural decline
| Period | Value |
|---|---|
| 2024 | 4.04% |
| 2023 | 43.90% |
| 2022 | 16.75% |
| 2021 | 50.80% |
| 2020 | 11.89% |
| 2019 | 32.26% |
| 2018 | 14.20% |
| 2017 | 22.27% |
| 2016 | 20.00% |
| 2015 | 58.78% |